PURPOSE: Neovascular AMD involves the activation of choroidal endothelial cells to increase their inflammatory and angiogenic behaviors. Elastin derived peptides (EDPs) can elicit some of these phenotypic changes in endothelial cells. This investigation was performed to follow up on those findings by determining a receptor for these peptides in the human eye as well as evaluating the effects of elevated EDPs on choroidal cells in vitro and in vivo. METHODS: The expression of elastin receptor genes including GLB1 was analyzed using reverse transcription PCR. Migration of choroidal endothelial cells was quantified in the presence of inhibitors to different EDP binding proteins. C57BL6 mice were injected with EDPs and studied by electroretinography, transmission electron microscopy, and microarray analysis. RESULTS: An alternatively spliced form of beta-galactosidase (GLB1) is present on human choroidal endothelial cells and acts as a receptor for EDPs. Elevated levels of circulating EDPs do not affect retinal function in the mouse, but do increase the expression and deposition of collagen IV in the RPE/choroid complex. CONCLUSIONS: EDPs may play a role in neovascular AMD by binding to and inducing neovascular phenotypes in choroidal endothelial cells through their receptor, GLB1. These peptides also cause an increased mRNA expression and deposition of collagen IV in the RPE/choroid, which may alter diffusion properties between the retina and choriocapillaris.
PURPOSE:Neovascular AMD involves the activation of choroidal endothelial cells to increase their inflammatory and angiogenic behaviors. Elastin derived peptides (EDPs) can elicit some of these phenotypic changes in endothelial cells. This investigation was performed to follow up on those findings by determining a receptor for these peptides in the human eye as well as evaluating the effects of elevated EDPs on choroidal cells in vitro and in vivo. METHODS: The expression of elastin receptor genes including GLB1 was analyzed using reverse transcription PCR. Migration of choroidal endothelial cells was quantified in the presence of inhibitors to different EDP binding proteins. C57BL6 mice were injected with EDPs and studied by electroretinography, transmission electron microscopy, and microarray analysis. RESULTS: An alternatively spliced form of beta-galactosidase (GLB1) is present on humanchoroidal endothelial cells and acts as a receptor for EDPs. Elevated levels of circulating EDPs do not affect retinal function in the mouse, but do increase the expression and deposition of collagen IV in the RPE/choroid complex. CONCLUSIONS:EDPs may play a role in neovascular AMD by binding to and inducing neovascular phenotypes in choroidal endothelial cells through their receptor, GLB1. These peptides also cause an increased mRNA expression and deposition of collagen IV in the RPE/choroid, which may alter diffusion properties between the retina and choriocapillaris.
Authors: H E Grossniklaus; J A Martinez; V B Brown; H M Lambert; P Sternberg; A Capone; T M Aaberg; P F Lopez Journal: Am J Ophthalmol Date: 1992-10-15 Impact factor: 5.258
Authors: Elliott H Sohn; Aditi Khanna; Budd A Tucker; Michael D Abràmoff; Edwin M Stone; Robert F Mullins Journal: Invest Ophthalmol Vis Sci Date: 2014-03-06 Impact factor: 4.799
Authors: Luke A Wiley; Erin R Burnight; Adam P DeLuca; Kristin R Anfinson; Cathryn M Cranston; Emily E Kaalberg; Jessica A Penticoff; Louisa M Affatigato; Robert F Mullins; Edwin M Stone; Budd A Tucker Journal: Sci Rep Date: 2016-07-29 Impact factor: 4.379